Hypothesis to explain poor outcomes in the ALLHAT and V-HeFT trials: decreased expression of heat shock proteins
An explanation for the higher incidence of cardiovascular disease and heart failure in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) with doxazosin and the Vasodilator Heart Failure Trial (V-HeFT) with prazosin might be decreased expression of heat shock pr...
Gespeichert in:
| Veröffentlicht in: | Curr Control Trials Cardiovasc Med |
|---|---|
| 1. Verfasser: | |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMC
2001
|
| Schlagworte: | |
| Online-Zugang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC64823/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11806806/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/cvm-2-6-251 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|